1. Hemoglobin, anemia, and clinical outcomes in vericiguat global study in subjects with heart failure with reduced ejection fraction (VICTORIA). (14th October 2021) Authors: Ezekowitz, J.A; Zheng, Y; Cohen-Solal, A; Melenovsky, V; Escobedo, J; Butler, J; Hernandez, A.F; Lam, C.S.P; O'Connor, C.M; Pieske, B; Ponikowski, P; Voors, A.A; McMullan, C; Roessig, L; Armstrong, P.W Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of vericiguat in patients with HFrEF treated with sacubitril/valsartan: results from the VICTORIA trial. (14th October 2021) Authors: Senni, M; Alemayehu, W; Sim, D; Edelmann, F; Butler, J; Ezekowitz, J.A; Hernandez, A.F; Lam, C.S.P; O'Connor, C.M; Pieske, B; Ponikowski, P; Roessig, L; Voors, A.A; McMullan, C; Armstrong, P.W Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗